IFIH1 and interstitial lung disease: Distinguished by its unique clinical profile, anti‐MDA5+ DM is notably characterised by minimal or absent muscular involvement and a profoundly perilous complication: rapidly progressive interstitial lung disease (RP‐ILD).1, 2